ModivCare Inc MODV.OQ MODV.O is expected to show a fall in quarterly revenue when it reports results on April 30 (estimated) for the period ending March 31 2025
The Denver Colorado-based company is expected to report a 5.6% decrease in revenue to $645.865 million from $684.45 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for ModivCare Inc is for a loss of 50 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had risen by about 120.0% in the last three months.
Wall Street's median 12-month price target for ModivCare Inc is $4.75, above its last closing price of $1.47.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.02
0.18
0.19
Beat
8
Sep. 30 2024
0.58
0.78
0.45
Missed
-41.9
Jun. 30 2024
0.80
0.77
-0.03
Missed
-103.9
Mar. 31 2024
0.24
0.19
-0.09
Missed
-146.6
Dec. 31 2023
1.32
1.28
1.29
Beat
0.9
Sep. 30 2023
1.17
1.11
1.44
Beat
29.3
Jun. 30 2023
1.71
1.62
1.47
Missed
-9.3
Mar. 31 2023
1.54
1.50
1.42
Missed
-5
This summary was machine generated April 28 at 11:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)